News Roche Introduces Ocrevus, Groundbreaking Therapy for Multiple Sclerosis in India Roche Pharma India unveils Ocrevus, a first-in-class treatment for both relapsing and primary progressive forms of multiple sclerosis (MS).
First Biosimilar First Biosimilar for Treating Multiple Sclerosis Receives FDA Approval A new era in multiple sclerosis treatment emerges as the FDA grants approval to the first-ever biosimilar for this condition.
